To characterize the genetic determinants of resistance to antituberculosis drugs, we performed
a genome-wide association study (GWAS) of 6,465 Mycobacterium tuberculosis clinical …

On the basis of population genomic and phylogeographic analyses of 1669 Mycobacterium
tuberculosis lineage 4 (L4) genomes, we find that dispersal of L4 has been completely …

Background The “fitness” of an infectious pathogen is defined as the ability of the pathogen
to survive, reproduce, be transmitted, and cause disease. The fitness of multidrug-resistant …

Background The emergence of SARS-CoV-2 has led to the development of serological
assays that could aid in an understanding of the burden of COVID-19 disease. Many available …

Recent advances in bacterial whole-genome sequencing have resulted in a comprehensive
catalog of antibiotic resistance genomic signatures in Mycobacterium tuberculosis. With a …

Background Paediatric inflammatory multisystem syndrome temporally associated with
SARS-CoV-2 (PIMS-TS) is a new, rare, post-infectious complication of SARS-CoV-2 infection in …

Background Tens of millions of children are exposed to Mycobacterium tuberculosis
globally every year; however, there are no contemporary estimates of the risk of developing …

Background Molecular diagnostics are considered the most promising route to achievement
of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC…

‘Long Covid’, or medical complications associated with post SARS-CoV-2 infection, is a
significant post-viral complication that is being more and more commonly reported in patients. …

Background BCG vaccines are given to more than 100 million children every year, but there
is considerable debate regarding the effectiveness of BCG vaccination in preventing …